Landscapes / Targets
TGF-β
23 drugs act on TGF-β, in 44 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs23
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
GARP/TGF-beta antibody |
AbbVie · Public ABBV |
Phase 2/3 | Nov 2026soonPhase 2 trial completes | ||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma, Advanced Solid Tumors Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | Nov 2026soonPhase 2 trial completes | |||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Pancreatic Neoplasms, Metastatic Pancreatic Ductal Adenocarcinoma | ||||
| Open drug page | |||||
— |
Hengrui · Public 600276.SS |
Phase 3 | 30 Jul 2027Phase 1/2 trial completes | ||
| Next date | 30 Jul 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Gastric or Gastroesophageal Junction Cancer, Relapsed or Advanced Non-small Cell Lung Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 2/3 | Mar 2028Phase 2 trial completes | |||
| Next date | Mar 2028 · Phase 2 trial completes | ||||
| Also tested for | Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma and 11 more | ||||
| Open drug page | |||||
— |
Phase 3 | Oct 2028Phase 2 trial completes | |||
| Next date | Oct 2028 · Phase 2 trial completes | ||||
| Also tested for | Degenerative Osteoarthritis, Degenerative Disc Disease | ||||
| Open drug page | |||||
— |
Phase 3 | 29 Dec 2028Phase 3 trial completes | |||
| Next date | 29 Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Solid Tumors, CRC (Colorectal Cancer) and 2 more | ||||
| Open drug page | |||||
— |
Phase 2/3 | Dec 2028Phase 2 trial completes | |||
| Next date | Dec 2028 · Phase 2 trial completes | ||||
| Also tested for | Malignant Pleural Mesothelioma, Pancreatic Ductal Adenocarcinoma | ||||
| Open drug page | |||||
— |
Phase 3 | Nov 2029Phase 3 trial completes | |||
| Next date | Nov 2029 · Phase 3 trial completes | ||||
| Also tested for | Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF) | ||||
| Open drug page | |||||
— |
Phase 2 | 1 Dec 2026soonPhase 2 trial completes | |||
| Next date | 1 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Solid Tumor, Adult, Cancer and 4 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Apr 2027Phase 1/2 trial completes | |||
| Next date | 30 Apr 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor, Gastrointestinal Cancer | ||||
| Open drug page | |||||
— |
Eli Lilly · Public LLY |
Phase 2 | Apr 2027Phase 2 trial completes | ||
| Next date | Apr 2027 · Phase 2 trial completes | ||||
| Also tested for | Osteoarthritis, Knee, Diabetic Neuropathic Pain and 1 more | ||||
| Open drug page | |||||
— |
Akeso · Public 9926.HK |
Phase 2 | May 2027Phase 1/2 trial completes | ||
| Next date | May 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma, Biliary Tract Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | May 2027Phase 1/2 trial completes | |||
| Next date | May 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 2 | 25 Jul 2027Phase 2 trial completes | |||
| Next date | 25 Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Submental Fullness | ||||
| Open drug page | |||||
— |
Sanofi · Public SNY |
Phase 1/2 | 13 Sep 2027Phase 1/2 trial completes | ||
| Next date | 13 Sep 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Plasma Cell Myeloma Refractory | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Sep 2027Phase 1/2 trial completes | |||
| Next date | 30 Sep 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Metastatic Pancreatic Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Osteosarcoma | ||||
| Open drug page | |||||
— |
Phase 2 | Jan 2028Phase 2 trial completes | |||
| Next date | Jan 2028 · Phase 2 trial completes | ||||
| Also tested for | Solid Tumor, Locally Advanced Solid Tumor and 2 more | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2028Phase 2 trial completes | |||
| Next date | Dec 2028 · Phase 2 trial completes | ||||
| Also tested for | Ovarian Cancer, Ovarian Neoplasms | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 23 of 23 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026